A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

NCT06457425 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

MF,PMF,PPV-MF,PET-MF

Interventions

DRUG: Flonoltinib 50mg
DRUG: Flonoltinib 100mg
DRUG: Ruxolitinib

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd